Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.28 - $1.16 $30,199 - $125,112
-107,856 Reduced 90.95%
10,727 $3,000
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $125,697 - $198,033
118,583 New
118,583 $137,000
Q2 2023

Aug 14, 2023

BUY
$1.14 - $1.95 $44,617 - $76,319
39,138 New
39,138 $72,000
Q2 2022

Aug 15, 2022

BUY
$2.2 - $4.2 $23,383 - $44,641
10,629 New
10,629 $25,000
Q1 2022

May 16, 2022

SELL
$2.83 - $8.69 $114,385 - $351,241
-40,419 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$8.31 - $14.92 $335,881 - $603,051
40,419 New
40,419 $336,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $11.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.